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Screening Effects
Eisemann and colleagues 
reported up-to-date 
nonmelanoma skin cancer 
incidence data from the 
German Schleswig–Holstein 
population. A pronounced 
incidence increase (by 47% 
for women and 34% for 
men) was found following 
the introduction of a pilot 
skin cancer screening project 
(SCREEN) in this region. This 
increase was not observed 
in the control population of 
Saarland, Germany, until the 
introduction of a nationwide 
skin cancer screening program. 
If future studies successfully 
implicate the screening 
program in this incidence 
increase, these data would 
support implementation of a 
population-based skin cancer 
screening program. See page 43
Information from 
Our PEERs
Global variation has been 
reported for eczema 
prevalence, suggesting that 
climatic factors may play a role 
in disease susceptibility. In 
addition, anecdotal evidence 
suggests that eczema flares 
are common during winter 
and summer months. Sargen 
and colleagues performed an 
analysis of data from 5,595 
children with eczema enrolled 
in the Pediatric Eczema 
Elective Registry Cohort from 
2004 to 2012. The data from 
this large-scale, prospective, 
longitudinal cohort study 
revealed that warm 
temperatures, high humidity, 
and high sun exposure are 
indeed associated with poorly 
controlled disease. See page 51
A Th1 Slant
Although discoid lupus erythematosus (DLE) is 
the most common skin manifestation of lupus, 
the immune-related pathways involved in this 
autoimmune disease are not completely under-
stood. This lack of information prevents break-
throughs in treatment options for a disease that is 
not effectively managed with currently approved 
first-line antimalarials. Using gene set enrich-
ment analysis, Jabbari and colleagues com-
pared DLE to the well-studied immune signature of psoriasis. Despite previous evidence 
to the contrary, DLE exhibited minimal T helper type 17 (Th17) involvement with skew-
ing toward a predominantly Th1 signature, highlighting the possibility of manipulation of 
IFN-γ or Th1-cell infiltrates to treat DLE. See page 87
Neuroendocrine Regulation in Hair Follicles
The hypothalamic–pituitary–thyroid (HPT) 
axis hormones are expressed in hair follicles 
(HF) and control mitochondrial function in 
the human epidermis. Vidali and colleagues 
found that these hormones rapidly stimu-
late gene expression in mitochondria and 
induce mitochondrial biogenesis in human 
scalp HFs. Thus, these hormones stimulate 
mitochondrial activity, and these effects are 
exerted on outer root sheath keratinocytes as 
opposed to within the hair matrix. The find-
ings indicate that mitochondrial biology, 
energy metabolism, and the redox state of human HFs are regulated by the neuroendo-
crine HPT hormones, and they offer a new avenue for exploring the use of these hormones 
in mitochondrial medicine. See page 33
Low Reaction Threshold
Despite the fact that transglutaminases (TG) are 
known to produce stable protein cross-links for 
an effective skin barrier, the recently generated 
TG3 knockout mouse exhibited impaired hair 
development but no defect in epidermal barrier 
function. Using a model of FITC contact hyper-
sensitivity, Bognar and colleagues observed in 
TGM3 knockout mice a clinically latent bar-
rier defect as measured by more invasive percu-
taneous penetration of FITC from the skin sur-
face. Moreover, these mice exhibited significant 
susceptibility to sensitization by FITC, indicating 
a reduced inflammatory threshold without a con-
comitant reduction in immune reactivity to pathogen challenge. Thus, TG3 contributes to 
a functionally intact epidermal barrier. See page 105
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